DICERNA PHARMACEUTICALS
Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. It is using ribonucleic acid interference (RNA) technology platform to develop its products. The product candidates are DCR-PHXC (for primary hyperoxaluria), DCR-undisclosed (for orphan genetic disease), DCR-PCSK9 (for cardiovascular disease), and DCR-HBV (for hepatitis B virus) among others. The company was founded in 2007 and is headquartered in Lexington, Massachusetts.
DICERNA PHARMACEUTICALS
Industry:
Biotechnology Genetics Health Care Pharmaceutical
Founded:
2007-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.dicerna.com
Total Employee:
101+
Status:
Closed
Contact:
6176126254
Total Funding:
271.45 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Domain Not Resolving Wordpress Plugins Sitelinks Search Box
Similar Organizations
A2A Pharmaceuticals
A2A Pharmaceuticals is a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents.
Accera
Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases.
Adcentrx Therapeutics
Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases
AGTC
AGTC is a biotechnology company conducting human clinical trials of AAV-based gene therapies for the treatment of rare diseases.
Aridis Pharmaceuticals
Aridis is a biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Biophytis
Biophytis is a research company that focuses on the fields of metabolic and age-related diseases.
Biosystems International
Biosystems International is a biotechnology company engaged in the development of blood-based diagnostics for cancer and chronic diseases.
CardioFocus
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Emerillon Therapeutics
Emerillon therapeutics is a biotechnology firm focused on the creation of innovative drug products for the treatment of infectious disease.
EquiTech Therapeutics, LLC
EquiTech Therapeutics, LLC's is a pioneer in the forward development of CRISPR-Cas9 genome editing for equine diseases and therapies.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Genecure
GeneCure is a biotechnology company providing treatments for life-threatening human diseases.
Homology Medicines
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
MagicMed Industries
MagicMed Industries is a privately-held biotechnology company focused on creating a library of novel derivative psychedelic molecules.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Parabase Genomics
Parabase Genomics is a molecular diagnostics company that focuses on the development of treatments for genetic disorders.
Regeneron
Regeneron Pharmaceuticals is a biotechnology company that invents life-transforming medicines for people with serious diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Vaccinex
Vaccinex is a biotechnology company engaged in the development of novel therapeutic antibodies for neurodegenerative disorders and oncology.
Verenium
Verenium is an industrial biotechnology company specializing in the development of high performance enzymes.
Vision Genomics
Vision genomics, LLC is a biotechnology company that focuses on research and development of therapeutics for age-related eye diseases.
ZaBeCor Pharmaceuticals
ZaBeCor Pharmaceuticals, LLC, a clinical stage biotechnology company, focuses on the development of siRNA, antisense, and other molecular
Current Advisors List
Board_member
2007-10-01
Board_member
2018-01-01
Board_member
Board_member
Board_member
2020-03-01
Current Employees Featured
Douglas Fambrough CEO @ Dicerna Pharmaceuticals
CEO
Rob Ciappenelli Chief Strategy Officer @ Dicerna Pharmaceuticals
Chief Strategy Officer
2021-09-01
Marc Abrams Senior Vice President, Discovery Research @ Dicerna Pharmaceuticals
Senior Vice President, Discovery Research
2021-09-01
Cheng Lai Executive Director @ Dicerna Pharmaceuticals
Executive Director
2013-10-01
Regina DeTore Paglia Chief Human Resources Officer @ Dicerna Pharmaceuticals
Chief Human Resources Officer
2019-02-01
Bob D. Brown CSO, SVP Research and Development @ Dicerna Pharmaceuticals
CSO, SVP Research and Development
2016-01-01
Emma Wright Senior Director, Manufacturing @ Dicerna Pharmaceuticals
Senior Director, Manufacturing
Kristen K. Sheppard, Esq. SVP, Investor Relations & Corporate Communications @ Dicerna Pharmaceuticals
SVP, Investor Relations & Corporate Communications
2021-09-01
Founder
Stock Details
Investors List
Eli Lilly
Eli Lilly investment in Post-IPO Equity - Dicerna Pharmaceuticals
Cowen Group
Cowen Group investment in Post-IPO Equity - Dicerna Pharmaceuticals
Skyline Ventures
Skyline Ventures investment in Post-IPO Debt - Dicerna Pharmaceuticals
Domain Associates
Domain Associates investment in Post-IPO Debt - Dicerna Pharmaceuticals
RA Capital Management
RA Capital Management investment in Post-IPO Debt - Dicerna Pharmaceuticals
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Debt - Dicerna Pharmaceuticals
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Post-IPO Debt - Dicerna Pharmaceuticals
Cormorant Asset Management
Cormorant Asset Management investment in Post-IPO Debt - Dicerna Pharmaceuticals
Abingworth
Abingworth investment in Series C - Dicerna Pharmaceuticals
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series C - Dicerna Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-22 | Dicerna Announces New Executive Leadership Appointments |
| 2020-05-07 | Dicerna Announces Appointment of Douglas Pagàn as Chief Financial Officer |
Official Site Inspections
http://www.dicerna.com Semrush global rank: 3.63 M Semrush visits lastest month: 3.94 K
- Host name: 142.202.38.30
- IP address: 142.202.38.30
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Dicerna Pharmaceuticals"
Dicerna Pharmaceuticals - Crunchbase Company …
Dicerna Pharmaceuticals is a biotechnology company with a focus on the development of innovative treatments for rare inherited diseases.See details»
DICERNA PHARMACEUTICALS, INC. - SEC.gov
Dec 31, 2020 Dicerna Pharmaceuticals, Inc. (“we,” “us,” “our,” “the Company,” or “Dicerna”) is a biopharmaceutical company focused on discovering, developing, and commercializing medicines that are designed to leverage ribonucleic acid …See details»
Dicerna Pharmaceuticals Inc - AnnualReports.com
Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers …See details»
Dicerna Announces New Executive Leadership Appointments
Sep 22, 2021 Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) is a biopharmaceutical company focused on discovering, developing and commercializing medicines that are designed to …See details»
Dicerna Pharmaceuticals, Inc. - LinkedIn
Dicerna Pharmaceuticals, Inc. | 31,062 followers on LinkedIn. Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to ...See details»
Dicerna - Ownership and Business Overview | Mergr
Dicerna is a biopharmaceutical company focused on discovering, developing, and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) …See details»
Novo Nordisk to Acquire Dicerna - Business Wire
Nov 18, 2021 Novo Nordisk and Dicerna have been parties to a research collaboration since 2019 to discover and develop RNAi therapies using Dicerna’s proprietary GalXC™ RNAi platform technology.See details»
Dicerna Pharmaceuticals Company Profile - Craft
Dicerna Pharmaceuticals is a clinical-stage biopharmaceutical company that focuses on the discovery and development of treatments for rare inherited diseases. It offers GalXC, a liver …See details»
Dicerna Pharmaceuticals Inc - Company Profile and News
Company profile page for Dicerna Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Dicerna Pharmaceuticals - Org Chart, Teams, Culture
View Dicerna Pharmaceuticals' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Dicerna Pharmaceuticals, Inc. Information - RocketReach
Dicerna Pharmaceuticals, Inc. is a Pharmaceutical Manufacturing, Pharmaceuticals, and Biotechnology company located in Lexington, Massachusetts with $192.8 million in revenue …See details»
Dicerna Pharmaceuticals Company Profile: Overview and Full News …
Dicerna Pharmaceuticals is a commercial company located in Massachusetts, specializing in the discovery and development of novel therapies to treat chronic conditions. With a focus on RNA …See details»
Dicerna Pharmaceuticals - Funding, Financials, Valuation & Investors
Dicerna Pharmaceuticals is a biotechnology company with a focus on the development of innovative treatments for rare inherited diseases.See details»
Dicerna Pharmaceuticals - Colorado BioScience Connect
Dicerna Pharmaceuticals. Dicerna Pharmaceuticals is a company that uses RNA interference (RNAi) to create medicines that silence the genes that cause or contribute to disease. They …See details»
Dicerna - Overview, News & Similar companies | ZoomInfo.com
Dec 24, 2021 View Dicerna (www.dicerna.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
DICERNA PHARMACEUTICALS, INC. - MarketScreener.com
Dec 27, 2021 Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing medicines that are designed to …See details»
Dicerna Pharmaceuticals - Contacts, Employees, Board Members, …
Dicerna Pharmaceuticals is a biotechnology company with a focus on the development of innovative treatments for rare inherited diseases.See details»
Dicerna Pharmaceuticals - Bain Capital Life Sciences
Dicerna Pharmaceuticals (Nasdaq: DRNA) is a biopharmaceutical company focused on discovering, developing and commercialising medicines that are designed to leverage RNAi to …See details»
Dicerna Pharmaceuticals CEO, Founder, Key Executive Team, Board …
Explore {Dicerna Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Dicerna Pharmaceuticals Careers and Employment | Indeed.com
Find out what works well at Dicerna Pharmaceuticals from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for popular …See details»